CYP3A induction by N-hydroxyformamide tumor necrosis factor-α converting enzyme/matrix metalloproteinase inhibitors: Use of a pregnane X receptor activation assay and primary hepatocyte culture for assessing induction potential in humans

Timothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao, Edward L. LeCluyse

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'CYP3A induction by N-hydroxyformamide tumor necrosis factor-α converting enzyme/matrix metalloproteinase inhibitors: Use of a pregnane X receptor activation assay and primary hepatocyte culture for assessing induction potential in humans'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences